Adipose-Derived Stem Cells and Their Derived Microvesicles Ameliorate Detrusor Overactivity Secondary to Bilateral Partial Iliac Arterial Occlusion-Induced Bladder Ischemia

Adipose-Derived Stem Cells and Their Derived Microvesicles Ameliorate Detrusor Overactivity Secondary to Bilateral Partial Iliac Arterial Occlusion-Induced Bladder Ischemia

(1) Background: We established a new bladder ischemia rat model through bilateral partial iliac arterial occlusion (BPAO) and investigated the therapeutic effect of adipose-derived stem cells (ADSCs) and ADSC-derived microvesicles (MVs); (2) Methods: The study included four groups: (1) sham, (2) BPA...

Full description

Bibliographic Details
Main Authors:	Bing-Juin Chiang, Chun-Hou Liao, Su-Han Mao, Chiang-Ting Chien
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	International Journal of Molecular Sciences
Subjects:	overactive bladder detrusor overactivity adipose-derived stem cells microvesicles bladder ischemia bilateral partial iliac arterial occlusion
Online Access:	https://www.mdpi.com/1422-0067/22/13/7000

Similar Items

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Short-term outcome of onabotulinumtoxin A injection for the treatment of refractory idiopathic detrusor overactivity
by: Gamal E A. Abourjila, et al.
Published: (2020-01-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

Cerebellar Ataxia and Overactive Bladder after Encephalitis Affecting the Cerebellum
by: Megumi Sugiyama, et al.
Published: (2009-07-01)

The influence of Potentilla chinensis aqueous extract on urinary bladder function in retinyl acetate-induced detrusor overactivity in rats
by: Andrzej Wróbel, et al.
Published: (2020-12-01)

Effects of a combination of herbal extracts (modified Ojayeonjonghwan (Wuzi Yanzong wan)) on partial urethral obstruction-induced detrusor overactivity in rats: impact on the nitric oxide pathway and oxidative stress
by: Sangrak Bae, et al.
Published: (2019-03-01)

The use of ultrasound-estimated bladder weight in diagnosing bladder outlet obstruction and detrusor overactivity in men with lower urinary tract symptoms
by: Fadi Housami, et al.
Published: (2009-01-01)

Accuracy of ultrasound-measured bladder wall thickness for the diagnosis of detrusor overactivity
by: M.M. Ali, et al.
Published: (2015-03-01)

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility
by: Chung-Cheng Wang, et al.
Published: (2016-03-01)

A pilot study of the use of fesoterodine in the management of men with refractory overactive bladder symptoms after surgery for bladder outlet obstruction
by: Bilal Chughtai, et al.
Published: (2015-03-01)

The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment
by: Eric Chieh-Lung Chou, et al.
Published: (2014-08-01)

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia
by: Tomonori Yamanishi, et al.
Published: (2015-06-01)

Efficacy and safety of tolterodine in subjects with symptoms of overactive bladder: An open label, noncomparative, prospective, multicentric study
by: Anant Kumar
Published: (2002-01-01)

Impairment of AMPK-α2 augments detrusor contractions in bladder ischemia
by: Jing-Hua Yang, et al.
Published: (2021-09-01)

Effect of Memantine on Overactive Detrusor in Rats With Spinal Cord Injury
by: Cüneyd Özkürkçügil, et al.
Published: (2010-05-01)

Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms
by: Vasileios Sakalis, et al.
Published: (2021-03-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Detrusor Smooth Muscle KV7 Channels: Emerging New Regulators of Urinary Bladder Function
by: John Malysz, et al.
Published: (2020-09-01)

Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivity
by: Christina L Fontaine, et al.
Published: (2017-01-01)

Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease
by: Gregory Vurture, et al.
Published: (2019-09-01)

OAB score: A clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study
by: Leandro Cristian Arribillaga, et al.

Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766
by: Bingsheng Li, et al.
Published: (2020-04-01)

Urinary Nerve Growth Factor Levels in Overactive Bladder Syndrome and Lower Urinary Tract Disorders
by: Hsin-Tzu Liu, et al.
Published: (2010-12-01)

Hyperactive bladder: concept of disease and paradigms in the treatment
by: G. G. Krivoborodov, et al.
Published: (2021-04-01)

A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors
by: Andrzej Wróbel, et al.
Published: (2020-03-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

Relationship between urodynamic patterns and lower urinary tract symptoms in Chinese women with a non-neurogenic bladder
by: Linhui Wang, et al.
Published: (2016-01-01)

Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis
by: Yuanshan Cui, et al.
Published: (2021-10-01)

Prevalence and urodynamic characteristics of detrusor overactivity with impaired contractility in the community-dwelling elderly with non-neurogenic lower urinary tract symptoms: Is it from a single or two independent bladder dysfunctions?
by: Seong Jin Jeong, et al.
Published: (2021-07-01)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

Electroacupuncture to treat with Overactive Bladder in Postmenopausal Women: study protocol for a multicenter, randomized, controlled, parallel clinical trial
by: Eun-Young Nam, et al.
Published: (2018-09-01)

Nonselective Blocking of the Sympathetic Nervous System Decreases Detrusor Overactivity in Spontaneously Hypertensive Rats
by: Chang-Shin Park, et al.
Published: (2012-04-01)

Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction
by: Long-Hu Jin, et al.
Published: (2011-09-01)

Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
by: N K Mohanty, et al.
Published: (2008-01-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Medical management of overactive bladder
by: Sarvpreet S Ubee, et al.
Published: (2010-01-01)

Detrusor after-contraction: a new insight
by: Françoise A. Valentini, et al.
Published: (2015-06-01)

Time-Related Changes in Detrusor Overactivity in Awake Rats with Spinal Cord Injury Observed by Simultaneous Registrations of Intravesical and Intraabdominal Pressures
by: Long-Hu Jin, et al.
Published: (2011-03-01)

Clinical Experience of the Use of Tolterodine in Patients with Overactive Bladder at Siriraj Hospital
by: Vitaya Titapant, et al.
Published: (2020-08-01)